A detailed history of Swiss National Bank transactions in Vericel Corp stock. As of the latest transaction made, Swiss National Bank holds 90,400 shares of VCEL stock, worth $5.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,400
Previous 90,400 -0.0%
Holding current value
$5.34 Million
Previous $4.15 Million 7.91%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$41.71 - $52.9 $37,539 - $47,610
900 Added 1.01%
90,400 $4.15 Million
Q1 2024

May 07, 2024

BUY
$32.52 - $52.33 $13,008 - $20,932
400 Added 0.45%
89,500 $4.66 Million
Q4 2023

Feb 06, 2024

SELL
$30.85 - $37.09 $314,670 - $378,318
-10,200 Reduced 10.27%
89,100 $3.17 Million
Q3 2023

Nov 08, 2023

BUY
$31.69 - $39.25 $38,028 - $47,100
1,200 Added 1.22%
99,300 $3.33 Million
Q2 2023

Aug 09, 2023

BUY
$29.0 - $38.37 $182,700 - $241,730
6,300 Added 6.86%
98,100 $3.69 Million
Q1 2023

May 10, 2023

SELL
$23.85 - $31.34 $255,195 - $335,338
-10,700 Reduced 10.44%
91,800 $2.69 Million
Q4 2022

Feb 08, 2023

BUY
$17.65 - $27.37 $33,535 - $52,003
1,900 Added 1.89%
102,500 $2.7 Million
Q3 2022

Nov 09, 2022

BUY
$22.62 - $32.54 $29,406 - $42,302
1,300 Added 1.31%
100,600 $2.33 Million
Q2 2022

Aug 09, 2022

BUY
$22.88 - $39.45 $121,264 - $209,085
5,300 Added 5.64%
99,300 $2.5 Million
Q1 2022

May 09, 2022

BUY
$31.69 - $43.29 $218,661 - $298,701
6,900 Added 7.92%
94,000 $3.59 Million
Q3 2021

Nov 08, 2021

BUY
$46.35 - $59.75 $46,350 - $59,750
1,000 Added 1.16%
87,100 $4.25 Million
Q2 2021

Aug 06, 2021

SELL
$47.2 - $67.81 $103,840 - $149,182
-2,200 Reduced 2.49%
86,100 $4.52 Million
Q1 2021

May 07, 2021

BUY
$30.93 - $59.48 $40,209 - $77,324
1,300 Added 1.49%
88,300 $4.91 Million
Q4 2020

Feb 05, 2021

SELL
$18.53 - $31.5 $87,091 - $148,050
-4,700 Reduced 5.13%
87,000 $2.69 Million
Q3 2020

Nov 09, 2020

BUY
$14.68 - $19.12 $20,552 - $26,768
1,400 Added 1.55%
91,700 $1.7 Million
Q2 2020

Aug 05, 2020

BUY
$8.5 - $15.82 $68,000 - $126,560
8,000 Added 9.72%
90,300 $1.25 Million
Q1 2020

May 08, 2020

BUY
$7.25 - $19.22 $15,225 - $40,362
2,100 Added 2.62%
82,300 $755,000
Q4 2019

Feb 06, 2020

BUY
$13.77 - $19.2 $38,556 - $53,760
2,800 Added 3.62%
80,200 $1.4 Million
Q2 2019

Aug 02, 2019

BUY
$15.01 - $18.89 $36,024 - $45,336
2,400 Added 3.2%
77,400 $1.46 Million
Q1 2019

May 10, 2019

BUY
$16.23 - $20.29 $51,936 - $64,928
3,200 Added 4.46%
75,000 $1.31 Million
Q4 2018

Feb 13, 2019

BUY
$10.77 - $18.44 $773,286 - $1.32 Million
71,800 New
71,800 $1.25 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.